SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS cuts Pacific Biosciences price target to $1.35 from $1.50

UBS cut its price target for Pacific Biosciences to $1.35 per share from $1.50,

PACB

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.